MedPath

Pharmacokinetics of asparaginase in patients with acute lymphoblastic leukemia: prospective observational study.

Not Applicable
Conditions
acute lymphoblastic leukemia (ALL)
Registration Number
JPRN-UMIN000040630
Lead Sponsor
Japan Children's Cancer Study Group(JCCG)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
110
Inclusion Criteria

Not provided

Exclusion Criteria

Judged to be inappropriate for registration by investigators

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The incidence of silent inactivation of asparaginase in patients with ALL.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath